AFG
GILD icon

Atomi Financial Group’s Gilead Sciences GILD Stock Holding History

Atomi Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.13M Buy
40,613
+1,488
+4% +$196K 0.13% 131
2026
Q1 		$5.45M Buy
39,125
+2,977
+8% +$417K 0.17% 113
2025
Q4 		$4.44M Sell
36,148
-2,847
-7% -$346K 0.13% 124
2025
Q3 		$4.33M Buy
38,995
+2,799
+8% +$318K 0.14% 118
2025
Q2 		$4.01M Buy
36,196
+13,003
+56% +$1.38M 0.15% 105
2025
Q1 		$2.6M Buy
23,193
+14,881
+179% +$1.54M 0.12% 135
2024
Q4 		$768K Buy
8,312
+2,231
+37% +$201K 0.04% 333
2024
Q3 		$510K Buy
6,081
+1,610
+36% +$123K 0.03% 443
2024
Q2 		$307K Sell
4,471
-809
-15% -$54K 0.02% 579
2024
Q1 		$387K Sell
5,280
-498
-9% -$38.3K 0.04% 434
2023
Q4 		$468K Buy
+5,778
New +$450K 0.06% 288

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atomi Financial Group's GILD Position: Q2 2026 in Review

Atomi Financial Group increased its Gilead Sciences (GILD) stake by 3.8% in Q2 2026, buying an estimated $196K and bringing the position to 40,613 shares worth $5.13M. The position accounts for 0.13% of the portfolio, ranked #131.

Atomi Financial Group first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.45M in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Atomi Financial Group held 40,613 shares of Gilead Sciences worth $5.13M as of Q2 2026.
  • Atomi Financial Group bought 1,488 Gilead Sciences shares in Q2 2026, an estimated $196K.
  • Gilead Sciences made up 0.13% of Atomi Financial Group's portfolio in Q2 2026, its #131 holding.
  • Atomi Financial Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Atomi Financial Group's Gilead Sciences position peaked at $5.45M in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.